Position in INM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$142,067
-$71,663 QoQ
Shares Held
220,260
+9.2% QoQ
Ownership
6.65%
of shares outstanding
% of Portfolio
2.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SABBY MANAGEMENT, LLC holds $273,392 across 2 Drug Manufacturers - Specialty & Generic names. INM ranks #1 (52.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INM |
InMed Pharmaceuticals Inc.
This page
|
220,260 | $142,067 | |
| 2 | SXTC |
China SXT Pharmaceuticals, Inc.
|
78,170 | $131,325 |
All Filings in INM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $142,067 | 220,260 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $296,946 | 280,138 | Shares | Sole | 2026-01-20 | |
| 2025-12-31 | $213,730 | 201,633 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $481,795 | 219,998 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $81,724 | 307,236 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $131,668 | 361,728 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $212,964 | 511,934 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $100,782 | 15,284 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||